The contract research organization (CRO) market presents a mix of numerous challenges and opportunities and is likely to provide pharmaceutical and biotechnology market participants the opportunity to achieve their strategic objectives by offering services that seek to reduce cost and time-to-market drug candidates. CROs are likely to capitalize on this tremendous opportunity by pursuing a mix of organic and inorganic growth initiatives that will ensure greater penetration of the market and higher share of R&D spending. Read more

Idea Cellular, an Aditya Birla Group Company, which is amongst the leading mobile operators in India, listed on the bourses today. It opened at Rs.85 on NSE and Rs.90 on BSE. Idea now has around 4,86,000 shareholders, with the Group’s Holding in excess of 57%. The Paid-up Share Capital is Rs.2592.86 crores. Read more